cancer chemotherapy · reviewed 2026-08-01
Etoposide and mayapple: a plant natural product reshaped into a topoisomerase medicine
Etoposide is a semisynthetic derivative of podophyllotoxin, a natural substance that NCI identifies as extracted from American mayapple. The related structures remain different products, and neither mayapple nor podophyllotoxin inherits the injection's oncology evidence.
Defined medicine
etoposide injection
VP-16 · semisynthetic epipodophyllotoxin
Where it came from
Etoposide is a semisynthetic derivative of podophyllotoxin, a natural substance extracted from Podophyllum peltatum. Chemical modification creates etoposide rather than merely purifying the plant molecule unchanged. dailymed-etoposide-2026 nci-etoposide
What it is trying to achieve
The cited injection is used in combination regimens for selected refractory testicular tumors and small-cell lung cancer. Its role belongs to specialist cancer care, not to the source plant or precursor. dailymed-etoposide-2026
How it acts
Etoposide's predominant macromolecular effect is induction of DNA strand breaks through interaction with DNA topoisomerase II. The label distinguishes this action from direct interference with microtubule assembly. dailymed-etoposide-2026 nci-etoposide
Why people developed this form
The sources establish that semisynthetic modification produced etoposide and that its labelled predominant effect is topoisomerase-II-associated DNA strand breaks; they do not establish a historical development goal for that structural change. dailymed-etoposide-2026 nci-etoposide
Present form and manufacture
The cited product is a sterile intravenous concentrate that uses pharmaceutical solvents to keep poorly water-soluble etoposide in solution. Formulation and controlled infusion are part of the labelled intervention. dailymed-etoposide-2026
Bioavailability
The label describes intravenous distribution, strong protein binding, metabolism, and renal and nonrenal clearance. Kidney impairment, serum albumin, and interacting medicines can change exposure or clearance; none of those data transfer to podophyllotoxin or mayapple. dailymed-etoposide-2026
Its own risks
Severe and sometimes fatal myelosuppression can lead to infection or bleeding. Other serious risks include hypersensitivity, low blood pressure during administration, tissue injury from extravasation, organ-specific exposure changes, and secondary leukemia. dailymed-etoposide-2026
What nature offers
No link below is assumed to be equivalent. Each names the organism or tradition, exact preparation, measured exposure, human evidence, and replacement boundary separately.
Nature link · Nature-inspired scaffold
podophyllotoxin from American mayapple
Podophyllum peltatum
American mayapple · podophyllotoxin natural-product lineage
- Exact material
- Podophyllotoxin extracted from the American mayapple source named by NCI, kept distinct from whole plant material, chemically modified etoposide, and the sterile injection formulation. nci-etoposide dailymed-etoposide-2026
- Relationship
- Nature-inspired scaffold. The medicine retains a natural-product molecular scaffold after deliberate structural change; the exact manufacturing route and development aim require separate evidence.
Lineage
Etoposide is a semisynthetic derivative that retains a podophyllotoxin natural-product scaffold after structural change. The sources support that parent relationship, not the stronger claim that a particular podophyllotoxin preparation is the immediate industrial starting material for the cited injection. nci-etoposide dailymed-etoposide-2026
Human evidence
Source, not an intervention Evidence product match: not applicable
Podophyllotoxin and mayapple explain the drug lineage but were not the labelled cancer intervention. The cited clinical purpose and safety controls belong to etoposide injection in defined combination regimens. nci-etoposide dailymed-etoposide-2026
Bioavailability and preparation
The label's distribution and clearance data concern intravenous etoposide. The cited sources provide no pharmacokinetic equivalence between that medicine and podophyllotoxin, root, resin, or another plant preparation. dailymed-etoposide-2026 nci-etoposide
Safety
The cited sources do not establish a safe oncology use for mayapple or podophyllotoxin. Etoposide injection itself requires specialist supervision because of severe toxicity. nci-etoposide dailymed-etoposide-2026
Can it replace the medicine?
Mayapple, podophyllotoxin, and plant extracts are not clinical substitutes for etoposide injection and have no equivalent role in the cited cancer regimens. nci-etoposide dailymed-etoposide-2026
The honest comparison
Etoposide retains a podophyllotoxin-derived scaffold after structural change. Its label names topoisomerase-II-associated DNA strand breaks and says it does not interfere with microtubule assembly; the finished injection adds formulation, exposure, combination-regimen evidence, and intensive safety monitoring. nci-etoposide dailymed-etoposide-2026
Mayapple deserves credit in etoposide's documented natural-product lineage. The useful medicine is not a gentler return to raw nature: it is a deliberately changed molecule whose cancer benefit and severe harms must be managed together. nci-etoposide dailymed-etoposide-2026
Sources for this card
- Etoposide injection prescribing information DailyMed · regulatory label · read 2026-08-01
- Etoposide definition US National Cancer Institute · official guidance · read 2026-08-01
Same card as data: /api/remedies/etoposide-podophyllotoxin-mayapple.json. Found a source or claim problem? Open a correction.